Selected research
Market Outlook & Growth Opportunities
Global Enteric Parasite Testing Market Outlook and Growth Opportunities 2026
Market perspective
The global Enteric Parasite Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Enteric Parasite Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Enteric Parasite Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Enteric Parasite Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Enteric Parasite Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Enteric Parasite Testing market include Abbott Laboratories, Diasorin, Biomérieux, Qiagen, Meridian Bioscience, Bio-Rad Laboratories and Thermo Fisher Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Enteric Parasite Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Enteric Parasite Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Enteric Parasite Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Enteric Parasite Testing market.
Enteric Parasite Testing Segment by Company
Abbott Laboratories
Diasorin
Biomérieux
Qiagen
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Enteric Parasite Testing Segment by Type
Microscopy
Enzyme Immunoassays
Molecular Diagnostics
Serological Tests
Enteric Parasite Testing Segment by Application
Research Institution
Hospital
Clinic
Enteric Parasite Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Enteric Parasite Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Enteric Parasite Testing key companies, revenue, market share, and recent developments.
3. To split the Enteric Parasite Testing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Enteric Parasite Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Enteric Parasite Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Enteric Parasite Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enteric Parasite Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enteric Parasite Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enteric Parasite Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Enteric Parasite Testing industry.
Chapter 3: Detailed analysis of Enteric Parasite Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Enteric Parasite Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Enteric Parasite Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Microscopy
- Enzyme Immunoassays
- Molecular Diagnostics
- Serological Tests
Applications
- Research Institution
- Hospital
- Clinic
Companies covered
- Abbott Laboratories
- Diasorin
- Biomérieux
- Qiagen
- Meridian Bioscience
- Bio-Rad Laboratories
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Enteric Parasite Testing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Enteric Parasite Testing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Enteric Parasite Testing Market Dynamics
- 2.1 Enteric Parasite Testing Industry Trends
- 2.2 Enteric Parasite Testing Industry Drivers
- 2.3 Enteric Parasite Testing Industry Opportunities and Challenges
- 2.4 Enteric Parasite Testing Industry Restraints
3 Enteric Parasite Testing Market by Company
- 3.1 Global Enteric Parasite Testing Company Revenue Ranking in 2025
- 3.2 Global Enteric Parasite Testing Revenue by Company (2021-2026)
- 3.3 Global Enteric Parasite Testing Company Ranking (2024-2026)
- 3.4 Global Enteric Parasite Testing Company Manufacturing Base and Headquarters
- 3.5 Global Enteric Parasite Testing Company Product Type and Application
- 3.6 Global Enteric Parasite Testing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Enteric Parasite Testing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Enteric Parasite Testing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Enteric Parasite Testing Market by Type
- 4.1 Enteric Parasite Testing Type Introduction
- 4.1.1 Microscopy
- 4.1.2 Enzyme Immunoassays
- 4.1.3 Molecular Diagnostics
- 4.1.4 Serological Tests
- 4.2 Global Enteric Parasite Testing Sales Value by Type
- 4.2.1 Global Enteric Parasite Testing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Enteric Parasite Testing Sales Value by Type (2021-2032)
- 4.2.3 Global Enteric Parasite Testing Sales Value Share by Type (2021-2032)
5 Enteric Parasite Testing Market by Application
- 5.1 Enteric Parasite Testing Application Introduction
- 5.1.1 Research Institution
- 5.1.2 Hospital
- 5.1.3 Clinic
- 5.2 Global Enteric Parasite Testing Sales Value by Application
- 5.2.1 Global Enteric Parasite Testing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Enteric Parasite Testing Sales Value by Application (2021-2032)
- 5.2.3 Global Enteric Parasite Testing Sales Value Share by Application (2021-2032)
6 Enteric Parasite Testing Regional Value Analysis
- 6.1 Global Enteric Parasite Testing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Enteric Parasite Testing Sales Value by Region (2021-2032)
- 6.2.1 Global Enteric Parasite Testing Sales Value by Region: 2021-2026
- 6.2.2 Global Enteric Parasite Testing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Enteric Parasite Testing Sales Value (2021-2032)
- 6.3.2 North America Enteric Parasite Testing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Enteric Parasite Testing Sales Value (2021-2032)
- 6.4.2 Europe Enteric Parasite Testing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Enteric Parasite Testing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Enteric Parasite Testing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Enteric Parasite Testing Sales Value (2021-2032)
- 6.6.2 South America Enteric Parasite Testing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Enteric Parasite Testing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Enteric Parasite Testing Sales Value Share by Country, 2025 VS 2032
7 Enteric Parasite Testing Country-level Value Analysis
- 7.1 Global Enteric Parasite Testing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Enteric Parasite Testing Sales Value by Country (2021-2032)
- 7.2.1 Global Enteric Parasite Testing Sales Value by Country (2021-2026)
- 7.2.2 Global Enteric Parasite Testing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Enteric Parasite Testing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Enteric Parasite Testing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Enteric Parasite Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Company Information
- 8.1.2 Abbott Laboratories Business Overview
- 8.1.3 Abbott Laboratories Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Laboratories Enteric Parasite Testing Product Portfolio
- 8.1.5 Abbott Laboratories Recent Developments
- 8.2 Diasorin
- 8.2.1 Diasorin Company Information
- 8.2.2 Diasorin Business Overview
- 8.2.3 Diasorin Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
- 8.2.4 Diasorin Enteric Parasite Testing Product Portfolio
- 8.2.5 Diasorin Recent Developments
- 8.3 Biomérieux
- 8.3.1 Biomérieux Company Information
- 8.3.2 Biomérieux Business Overview
- 8.3.3 Biomérieux Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
- 8.3.4 Biomérieux Enteric Parasite Testing Product Portfolio
- 8.3.5 Biomérieux Recent Developments
- 8.4 Qiagen
- 8.4.1 Qiagen Company Information
- 8.4.2 Qiagen Business Overview
- 8.4.3 Qiagen Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
- 8.4.4 Qiagen Enteric Parasite Testing Product Portfolio
- 8.4.5 Qiagen Recent Developments
- 8.5 Meridian Bioscience
- 8.5.1 Meridian Bioscience Company Information
- 8.5.2 Meridian Bioscience Business Overview
- 8.5.3 Meridian Bioscience Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
- 8.5.4 Meridian Bioscience Enteric Parasite Testing Product Portfolio
- 8.5.5 Meridian Bioscience Recent Developments
- 8.6 Bio-Rad Laboratories
- 8.6.1 Bio-Rad Laboratories Company Information
- 8.6.2 Bio-Rad Laboratories Business Overview
- 8.6.3 Bio-Rad Laboratories Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
- 8.6.4 Bio-Rad Laboratories Enteric Parasite Testing Product Portfolio
- 8.6.5 Bio-Rad Laboratories Recent Developments
- 8.7 Thermo Fisher Scientific
- 8.7.1 Thermo Fisher Scientific Company Information
- 8.7.2 Thermo Fisher Scientific Business Overview
- 8.7.3 Thermo Fisher Scientific Enteric Parasite Testing Revenue and Gross Margin (2021-2026)
- 8.7.4 Thermo Fisher Scientific Enteric Parasite Testing Product Portfolio
- 8.7.5 Thermo Fisher Scientific Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst